| |
| | Zidovudine (Retrovir, azidothymidine, AZT) |
 | | Zidovudine should be considered in choosing therapy for individuals experiencing viral recurrence on prior regimens, but resistance testing may be helpful in assessing the utility of zidovudine in the individual situation. |
 | | In a retrospective analysis, zidovudine was found to be effective in reducing the risk of HIV infection following occupational exposure.(8) For this reason, zidovudine is generally included in post-exposure prophylaxis regimens, although in cases of likely exposure to zidovudine-resistant HIV, the use of alternative agents is consistent with USPHS guidelines. |
 | | Zidovudine regimens including antenatal, peripartum, and neonatal treatment have shown a dramatic reduction in mother-to-child transmission of HIV in previously untreated mothers.(9) Currently the USPHS recommends the inclusion of zidovudine in an effective antenatal regimen when possible, but not when stavudine is part of the preferred maternal treatment. |
| hivinsite.ucsf.edu /InSite.jsp?page=ar-drugs&doc=ar-01-01 (1213 words) |
|